This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its trifluoromethyl group enhances the biological activity and metabolic stability of the resulting drugs, making it valuable in the development of medications targeting central nervous system disorders, inflammation, and certain types of cancers. Additionally, it serves as a building block in organic synthesis for creating complex molecules with potential therapeutic applications. Its unique structure also makes it a candidate for research in agrochemicals, particularly in the design of herbicides and pesticides with improved efficacy.